RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.

Vaccination coverage in the Netherlands rose more sharply this week than in previous weeks, increasing to 81.7% among people aged 18 years and older and 79.0% among those aged 12 years and older.

RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today.  The open data now includes vaccination turnout and coverage by municipality for three age groups.

Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.

Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.

In the week from 17 to 23 March, 46,005 people received a positive test result for COVID-19, an increase of 16% compared to the week before that. The reproduction number continued to rise, from 1.06 on 1 March to 1.11 on 8 March.

The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.

The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.